Diabetes Diagnostics Market Expansion Outlook: $36.42 Billion by 2029 Forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Diabetes Diagnostics Market Between 2025 And 2029?

The diabetes diagnostics market size has exhibited robust growth in recent years. It is anticipated to increase from $25.39 billion in 2024 to $27.31 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.6%. The expansion observed in past periods can be credited to factors such as the rising prevalence of diabetes, an expanding geriatric population, an increase in sedentary lifestyles, the growing adoption of minimally invasive diagnostic methods, and a rising prevalence of obesity.

The diabetes diagnostics market is anticipated to experience substantial expansion in the coming years. By 2029, its valuation is projected to reach $36.42 billion, achieving a compound annual growth rate (CAGR) of 7.5%. This projected growth is driven by several factors, including the increasing use of insulin pumps, continuous innovation in diabetes technology, a rise in unhealthy lifestyles, the escalating incidence of type 1 and type 2 diabetes, and the development of healthcare infrastructure. Key developments during this period are expected to involve progress in biosensor technology, broader technological innovations, improvements in diagnostic methods, the emergence of personalized medicine and targeted therapies, and sophisticated advancements in in vitro diagnostic products.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

What Are The Top Growth Drivers Impacting The Diabetes Diagnostics Market Outlook?

The increasing incidence of obesity is projected to boost the expansion of the diabetes diagnostics market. Obesity is characterized by an excessive build-up of body fat, elevating the likelihood of various medical issues like heart disease and diabetes. The rising rates of obesity are linked to factors such as inactive lifestyles, greater intake of processed and high-calorie foods, genetic factors, and insufficient physical activity. Diabetes diagnostics play a crucial role in managing obesity by detecting early signs of insulin resistance and glucose metabolism problems, allowing for prompt actions to avert further weight gain and associated health complications. For example, in September 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, 22 states recorded an adult obesity rate of 35% or higher, up from 19 states in 2021. Consequently, the widespread prevalence of obesity is stimulating the growth of the diabetes diagnostics market.

What Are The Different Segment Classifications Within The Diabetes Diagnostics Market?

The diabetes diagnosticsmarket covered in this report is segmented –

1) By Product Type: Blood Glucose Meters; Continuous Glucose Monitoring Devices; Lancets; Test Strips; Other Product Types

2) By Diabetes Type: Diabetes I; Diabetes II; Gestational Diabetes

3) By End-User: Hospitals; Diagnostic Centers; Homecare Settings; Other End-Users

Subsegments:

1) By Blood Glucose Meters: Traditional Blood Glucose Meters; Smart Blood Glucose Meters; Bluetooth-enabled Blood Glucose Meters

2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems; Implantable CGM Systems; Flash Glucose Monitoring Devices

3) By Lancets: Single-use Lancets; Multi-use Lancets

4) By Test Strips: Standard Test Strips; Smart Test Strips

5) By Other Product Types: Hemoglobin A1c Testing Kits; Urine Glucose Test Strips; Blood Ketone Meters

What Long-Term Trends Will Shape The Future Growth Of The Diabetes Diagnostics Industry?

Leading companies in the diabetes diagnostics sector are focusing on the development of innovative products, such as gestational diabetes diagnostics tools, to expand their offerings and address the increasing demand for early detection and management of diabetes during pregnancy. A gestational diabetes diagnostic tool refers to medical devices or tests employed to identify and monitor gestational diabetes in expectant mothers, typically involving blood glucose testing, like the oral glucose tolerance test (OGTT), to assess how efficiently the body processes sugar throughout gestation. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced the XpressGT RUO kit, a pioneering biosensor tool designed for detecting insulin resistance-related conditions such as gestational diabetes, endometriosis, and liver disease. This kit offers rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with standard clinical analyzers. This innovation aims to provide early diagnostics, with the potential to improve outcomes for millions of patients globally.

Which Leading Companies Dominate The Diabetes Diagnostics Market Share?

Major companies operating in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Diabetes Diagnostics Market?

North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Diabetes Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp

Browse Through More Reports Similar to the Global Diabetes Diagnostics Market 2025, By The Business Research Company

Digital Diabetes Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

Diabetes Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

Artificial Intelligence In Diabetes Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795